Fibrosarcoma — Trials

Fibrosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 11
Ph III recruiting: 0
Growth YoY: —
Industry share: 27%
Top sponsor: Oslo University Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02601209	Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma	terminated	Phase 1 / Phase 2	151	National Cancer Institute (NCI)NIH	1	Aug 23, 2022	clinicaltrials
NCT00003292	S9624 Ifosfamide in Treating Patients With Meningeal Tumors	terminated	Phase 2	7	SWOG Cancer Research NetworkNETWORK	4	Nov 8, 2013	clinicaltrials